Bicycle Therapeutics Stock Quote BCYC - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

23.22

Bid

23.22

Ask

29.99

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

1.603B

Previous Close

23.22

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

69,046,021

Dividend Yield

PE Ratio

-8.87

Earnings Per Share (EPS)

-2.62

Revenue

26.98M

Net Profit

-180.66M

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused... Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.bicycletherapeutics.com

Headquarters

Cambridge, Gbr

Founded

Bicycle Therapeutics PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BCYC. The last closing price for Bicycle Therapeutics was $23.22. Over the last year, Bicycle Therapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Bicycle Therapeutics currently has 69,046,021 shares outstanding. The market capitalization of Bicycle Therapeutics is $1.60 billion. Bicycle Therapeutics has a price to earnings ratio (PE ratio) of -8.87.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today...

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on November 1, 2024, the Compensation Committee of the company’s Board of Directors granted to twelve new employees inducement awards...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

Presented updated clinical results across oncology pipeline, including a 45% overall response rate (ORR) for zelenectide pevedotin monotherapy and a 45% ORR for BT5528 6.5 mg/m2 every two weeks...

Form 8-K - Current report

Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals

First human imaging data validate the potential of MT1-MMP as a novel target in the treatment of cancer and demonstrate positive properties of Bicycle Radionuclide Conjugates (BRC®) for...

Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress

Company to host conference call and webcast on Wednesday, Oct. 23, at 8 a.m. ET to review the data and outline radiopharmaceuticals strategy Bicycle Therapeutics plc (NASDAQ: BCYC), a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LGHLWLion Group Holding Ltd	$ 0.03 (279.75%)	1
ELABElevai Labs Inc	$ 0.0483 (95.55%)	147.09M
SVMHSRIVARU Holding Ltd	$ 0.0359 (48.35%)	30.02M
ZCARZoomcar Holdings Inc	$ 8.96 (37.85%)	41.91k
XTIAXTI Aerospace Inc	$ 0.0787 (37.59%)	18.25M
DBGIDigital Brands Group Inc	$ 0.1347 (-25.50%)	1.52M
HROWHarrow Inc	$ 38.90 (-24.90%)	16.09k
ELVNEnliven Therapeutics Inc	$ 20.00 (-22.48%)	90
BJDXBluejay Diagnostics Inc	$ 0.0809 (-22.21%)	244.77k
BHRBBurke and Herbert Financial Services Corporation	$ 55.10 (-20.62%)	90
ELABElevai Labs Inc	$ 0.0483 (95.55%)	147.09M
SVMHSRIVARU Holding Ltd	$ 0.0359 (48.35%)	30.02M
XTIAXTI Aerospace Inc	$ 0.0787 (37.59%)	18.25M
MVSTMicrovast Holdings Inc	$ 0.9267 (16.55%)	6.93M
QUBTQuantum Computing Inc	$ 3.31 (24.44%)	5.31M